Evabosmig
Evabosmig (AGA2118) is a bispecific antibody targeting SOST/sclerostin and DKK-1. Evabosmig binds to both SOST and DKK-1 simultaneously, activates the Wnt/β-catenin signaling pathway, and thereby potently promotes osteogenesis. Evabosmig can be used for the study of osteoporosis.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3061142-96-6
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
immunoglobulin (H-gamma4_L-kappa) (H-gamma4_L-kappa)
Human
SOST/Sclerostin & DKK1
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG4-kappa
ELISA, FACS, Functional assay
Chemical Information
-
CAS. Nr. 3061142-96-6
-
SMILES
[Evabosmig]
-
Synonyms
AGA2118
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)